Yun, Seongseok <br/><br/>
Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  06 2016 
 - e85-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2016.03.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Disease Progression<br/>Female<br/>Fusion Proteins, bcr-abl--genetics<br/>Humans<br/>Imatinib Mesylate--administration & dosage<br/>Leukemia, Myeloid, Chronic-Phase--diagnosis<br/>Male<br/>Mutation<br/>Odds Ratio<br/>Protein Kinase Inhibitors--administration & dosage<br/>Publication Bias<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome